At first glance, VGT and VHT do not compete directly: one targets information technology, the other health care. Yet they are frequently weighed against each other by investors deciding where to place a single-sector allocation within a diversified portfolio. Both are low-cost, index-tracking Vanguard ETFs with long operating histories, but they represent opposite ends of the risk-and-return spectrum — a growth-oriented, momentum-heavy sector versus a defensive, innovation-driven one. This ETF comparison examines their structural differences, sector exposure, fund performance, and relative positioning to help investors determine which vehicle better fits current market conditions. I also checked this using Tickeron’s AI Screener to see how the two line up against broader sector peers.
VGT is a passively managed ETF that seeks to track the MSCI US Investable Market Information Technology 25/50 Index, a benchmark covering large-, mid-, and small-cap U.S. technology companies classified under the GICS (Global Industry Classification Standard). The fund holds roughly 310 to 320 stocks, with approximately 99.8% of assets in the information technology sector.
Its portfolio is notably top-heavy. NVDA, MSFT, and AAPL together represent close to 45% of assets, followed by AVGO, ORCL, and other software, semiconductor, and hardware leaders. The fund uses a market-cap-weighted, full-replication approach, rebalancing as index constituents change. Its expense ratio of 0.09% makes it one of the least expensive technology funds available. The distinguishing feature is its concentration in the companies driving the artificial-intelligence and cloud-computing buildout, which amplifies both upside potential and drawdown risk.
VHT is a passively managed ETF tracking the MSCI US Investable Market Health Care 25/50 Index, spanning large-, mid-, and small-cap U.S. health care companies under GICS. It holds roughly 400 stocks, with essentially 100% of assets in the health care sector.
Top holdings include LLY, JNJ, ABBV, UNH, MRK, and TMO, representing pharmaceuticals, managed care, medical devices, and life-sciences tools. Like VGT, it uses a market-cap-weighted, full-replication methodology with an expense ratio of 0.09%. VHT's structure spreads risk across multiple health care sub-industries, reducing single-name concentration relative to VGT and producing a lower beta and more moderate volatility profile.
The two sectors face very different catalysts. Technology is being propelled by sustained artificial-intelligence investment, data-center expansion, and demand for accelerated computing, driving capital flows into semiconductor and software leaders. Health care, by contrast, is shaped by drug-pricing policy debates, patent cliffs, and the long-running productivity of GLP-1 and oncology pipelines. Macroeconomic forces such as interest-rate expectations affect both but differently: technology's higher duration and valuation sensitivity make it more reactive to rate shifts, while health care's defensive earnings provide ballast in risk-off environments. Regulatory scrutiny, in the form of antitrust attention on large technology firms and pricing pressure on pharmaceutical and managed care companies, remains a shared but distinct risk.
Across recent weeks and market cycles, VGT has generally outpaced VHT, reflecting persistent leadership from its top semiconductor and software holdings and broad investor enthusiasm for AI-related earnings growth. VHT has lagged on a relative basis, pressured by policy uncertainty and mixed performance among large managed care and pharmaceutical constituents. In terms of relative positioning, VGT offers higher momentum but also larger drawdowns during risk-off periods, while VHT's lower beta provides a smoother ride. Investors seeking growth acceleration have favored VGT, whereas those prioritizing capital preservation and lower volatility have leaned toward VHT. From what I see, the divergence highlights how sector-specific themes play out over time.
In my own analysis, Tickeron's AI Screener has proven helpful for quickly comparing sector exposures and momentum signals across ETFs like these. It allows filtering by technical patterns, fundamentals, and performance metrics, which can surface ideas that might otherwise take longer to identify manually. I have used it to cross-check relative strength between technology and health care holdings without replacing broader due diligence.
Based on observable factors, Tickeron's AI would likely favor VGT over VHT in the current environment. VGT combines a rock-bottom expense ratio with consistent trend momentum, concentrated leadership in the AI capital-expenditure cycle, and stronger relative performance across recent market cycles. While VHT offers lower beta and defensive diversification, its momentum has been comparatively subdued. Given VGT's structural strength, cost efficiency, and sector leadership, the AI framework leans toward VGT as the favored ticker — though its higher volatility means the choice ultimately depends on an investor's risk tolerance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Aroon Indicator for VGT entered a downward trend on November 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 144 similar instances where the Aroon Indicator formed such a pattern. In 126 of the 144 cases the stock moved lower. This puts the odds of a downward move at 88%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VGT as a result. In 73 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
VGT moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VGT crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where VGT advanced for three days, in 335 of 385 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
VGT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows